Oral Curcumin With Piperine as Adjuvant Therapy for the Treatment of COVID-19: A Randomized Clinical Trial.

Pawar, Kirti S; Mastud, Rahul N; Pawar, Satheesh K; Pawar, Samragni S; Bhoite, Rahul R; Bhoite, Ramesh R; Kulkarni, Meenal V; Deshpande, Aditi R

Pawar, Kirti S; Mastud, Rahul N; Pawar, Satheesh K; Pawar, Samragni S; Bhoite, Rahul R; Bhoite, Ramesh R; Kulkarni, Meenal V; Deshpande, Aditi R.

Afiliação

Pawar KS; Giriraj Hospital and Intensive Care unit, Baramati, India.
Mastud RN; Giriraj Hospital and Intensive Care unit, Baramati, India.
Pawar SK; Siddhivinayak Ultrasound Research Center, Baramati, India.
Pawar SS; HBT Medical College and Dr R N Cooper Municipal General Hospital, Mumbai, India.
Bhoite RR; Medstar Good Samaritan Hospital, Baltimore, MD, United States.
Bhoite RR; Giriraj Hospital and Intensive Care unit, Baramati, India.
Kulkarni MV; Department of Preventive and Social Medicine, N K P Salve Medical College Nagpur, Nagpur, India.
Deshpande AR; Freelance Statistician, Nagpur, India.

Front Pharmacol ; 12: 669362, 2021.

Article em En | MEDLINE | ID: mdl-34122090

Palavras-chave

COVID-19; adjuvant therapy; anti-inflammatory; curcumin; post-covid thromboembolic episodes; traditional medicine

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Métodos Terapêuticos e Terapias MTCI: Terapias_biologicas / Aromoterapia / Plantas_medicinales Tipo de estudo: Clinical_trials Idioma: En Revista: Front Pharmacol Ano de publicação: 2021 Tipo de documento: Article País de afiliação: Índia

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google